Please login to the form below

Not currently logged in
Email:
Password:

AstraZeneca backs heart website

Works with charity HEART UK on How Young My Heart
AZ

AstraZeneca has collaborated on the development of a new website that aims to encourage more people to discuss the health of their heart.

The company worked with cholesterol charity HEART UK on the How Young My Heart website, where users can take a one-minute questionnaire to find out what age their heart could be.

Commenting on the campaign, Lisa Anson, country president, AstraZeneca UK and Ireland, said: “Many people are totally unaware of their heart health, despite more than half of adults in England having raised cholesterol.

“Collaborating with HEART UK, we hope the How Young My Heart campaign will generate more conversation and awareness around the importance and benefits of having a healthy heart.”

She added: “We encourage men and women over the age of 25 and who are interested in the health of their heart to visit the campaign website.”

Each time the questionnaire is completed and shared on Twitter or Facebook with the hashtag #NCM, AstraZeneca will donate 25p to HEART UK, up to a total of £10,000.

HEART UK chief executive Jules Payne said: "The development of the 'How Young My Heart' website has created a great opportunity to talk more about the importance of heart health and the prevention of heart disease in the United Kingdom.”

National Cholesterol Month 2015 - October in the UK - is themed 'The Great Cholesterol Challenge'. It aims to encourage people to pledge to adopt a new healthy habit, and to raise funds for HEART UK.

The charity works to raise awareness of the risks of high cholesterol, which it calls 'the silent killer'. 

Article by
Tara Craig

28th October 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics